MBX Biosciences Financials - Benzinga

MBX Biosciences Inc

MBXNASDAQ

Trade with Public

Trade with Public

$53.63

-1.76-3.18%

近くで: Sep 25, 5:00 PM EST

$53.63

N/A

時間外: 4:00 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

MBX Biosciences Financials

MBX Biosciences (MBX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
MBX Biosciences Q2 EPS $(0.78) Misses $(0.63) Estimate

MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.63) by 23.81 percent. This is a 34.48 percent decrease over losses of $(0.58) per share from

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights

PRO
MBX Biosciences Q1 EPS $(0.51) Beats $(0.61) Estimate

MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.61) by 16.39 percent. This is a 28.17 percent increase over losses of $(0.71) per share from

Benzinga Newsdesk

PRO
MBX Biosciences Q4 EPS $(0.49) Beats $(0.68) Estimate

MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.68) by 27.84 percent. This is a 4.26 percent decrease over losses of $(0.47) per share from the

Benzinga Newsdesk

Earnings Scheduled For February 12, 2026

Benzinga Insights

Earnings Scheduled For December 18, 2025

Benzinga Insights

© 2026 Benzinga | All Rights Reserved